Page last updated: 2024-10-31

nafamostat and Hypertriglyceridemia

nafamostat has been researched along with Hypertriglyceridemia in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goto, S	1
Ookawara, S	1
Tabei, K	1

Other Studies

1 other study available for nafamostat and Hypertriglyceridemia

Article	Year
Effectiveness of Plasma Exchange for Acute Pancreatitis Induced by Hypertriglyceridemia During Pregnancy. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:1 Topics: Adult; Anticoagulants; Benzamidines; Disseminated Intravascular Coagulation; Female; Guanidines; Hum	2016

Article

Year

Effectiveness of Plasma Exchange for Acute Pancreatitis Induced by Hypertriglyceridemia During Pregnancy.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:1

Topics: Adult; Anticoagulants; Benzamidines; Disseminated Intravascular Coagulation; Female; Guanidines; Hum

2016